Position in NVO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$15,868
+$3,704 QoQ
Shares Held
331
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,208
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthAvenue LLC holds $434,578 across 9 Drug Manufacturers - General names. NVO ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,141 | $289,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
562 | $72,217 | |
| 3 | ABBV |
AbbVie Inc.
|
118 | $29,693 | |
| 4 | LLY |
ELI LILLY & Co
|
21 | $25,188 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
331 | $15,868 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6 | $758 | |
| 7 | AMGN |
Amgen Inc
|
2 | $724 | |
| 8 | BIIB |
Biogen Inc.
|
1 | $216 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,868 | 331 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $12,164 | 331 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $16,841 | 331 | Shares | Sole | 2026-04-02 | |
| No filing history on record for this holder in this stock. | ||||||